申请人:University of Kentucky Research Foundation
公开号:US10208000B2
公开(公告)日:2019-02-19
Provided herein are novel small-molecules that have use in the inhibition of Eis, which mediates kanamycin resistance in Mycobacterium tuberculosis. The presently-disclosed subject matter further includes a pharmaceutical composition including a small molecule inhibitor, as described herein, and a suitable pharmaceutical carrier. Methods of treating tuberculosis comprising administering to an individual an effective amount of the disclosed small molecule inhibitors to mediate kanamycin A resistance and treat tuberculosis are also provided.
本文提供的新型小分子可用于抑制介导结核分枝杆菌卡那霉素耐药性的 Eis。目前公开的主题还包括一种药物组合物,其中包括本文所述的小分子抑制剂和合适的药物载体。还提供了治疗结核病的方法,包括向个体施用有效量的所公开的小分子抑制剂,以介导卡那霉素 A 抗性和治疗结核病。